Los Angeles Capital Management LLC Seres Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$5.09 - $9.05 $89,360 - $158,881	-17,556 Reduced 21.77%	63,094 $353,000
Q3 2022 Nov 02, 2022	SELL	$3.5 - $7.2 $86,684 - $178,322	-24,767 Reduced 23.49%	80,650 $518,000
Q2 2022 Aug 05, 2022	BUY	$2.7 - $7.62 $104,816 - $295,816	38,821 Added 58.29%	105,417 $362,000
Q1 2022 May 06, 2022	BUY	$6.3 - $8.84 $315 - $442	50 Added 0.08%	66,596 $474,000
Q4 2021 Feb 03, 2022	SELL	$6.02 - $11.43 $1,300 - $2,468	-216 Reduced 0.32%	66,546 $554,000
Q3 2021 Nov 08, 2021	BUY	$5.46 - $22.6 $364,520 - $1.51 Million	66,762 New	66,762 $465,000

41.1M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $100M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.